Loading…
Loading…
CMC's core EBITDA surges y/y in the first nine months of fiscal 2026, aided by acquisitions, margin expansion and TAG Program benefits.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
[url="]Celularity Inc.[/url] (Nasdaq: CELU) (âCelularityâ), a longevity-focused regenerative and cellular medicine company, and [url="]MuseCell InnovationsÂ
IRVING, Texas, Aug. 27, 2026 /PRNewswire/ -- CMC (NYSE: CMC) today announced that it has been named to Newsweek's America's Greatest Companies 2026 list. The annual ranking, developed by Newsweek in partnership with Plant-A Insights Group, recognizes 650 U.S. companies based on financial leadership, innovation, performance as an employer and sustainability.
Commercial Metals Company is executing a strategy focused on higher-margin, less capital-intensive operations following $2.5 billion in transformative M&A. Commercial Metals targets $1.65–$1.80 billion core EBITDA and $11B revenue by 2029, aiming to nearly double free cash flow per share. Leverage remains in the low 2s as Commercial Metals prioritizes EBITDA growth and shareholder returns via increased buybacks over rapid debt reduction.
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological